Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Cytek Biosciences Scores $120M Series D Round

2020-11-06
FREMONT, CA, Cytek Biosciences has closed a $120 million Series D funding round.
Cytek Biosciences, a provider of cell analysis instrumentation and solutions, has closed a $120 million Series D funding round, co-led by RA Capital and Hillhouse Capital, with OrbiMed and LYFE Capital also participating.

Cytek Biosciences is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors